GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 7, 2025
GlobeImmune Market Cap
GlobeImmune has a market cap or net worth of $575.00 as of July 16, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
575.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 2, 2014, GlobeImmune's market cap has decreased from 60.99M to 575.00, a decrease of -100.00%. That is a compound annual growth rate of -65.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 553.58M |
| Glass House Brands | 545.56M |
| CytoDyn | 394.14M |
| American Oncology Network | 343.79M |